PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90720612 |
Filing Date: 05/19/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90720612 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\907\206\90720612\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | BOREALIS |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) green, blue, and purple is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the wording BOREALIS in stylized lettering and the design of three different-sized triangles superimposed over one another and positioned facing rightward, with the forewardmost triangle being shaded in green, the middle-ground triangle being shaded in blue, and the rear triangle being shaded in purple, and the color of the most western side of each triangle fading into a non-distinct edge. |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 286 x 155 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Dicerna Pharmaceuticals, Inc. |
*MAILING ADDRESS | 75 Hayden Avenue |
*CITY | Lexington |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02421 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Pharmaceutical product development and evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Glenn A. Gundersen |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Dechert LLP |
STREET | 2929 Arch Street, Cira Centre |
CITY | Philadelphia |
STATE | Pennsylvania |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 19104-2808 |
EMAIL ADDRESS | trademarks@dechert.com |
CORRESPONDENCE INFORMATION | |
NAME | Glenn A. Gundersen |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@dechert.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Byron Olsen/ |
SIGNATORY'S NAME | Byron Olsen |
SIGNATORY'S POSITION | Vice President, Intellectual Property |
SIGNATORY'S PHONE NUMBER | 3145208396 |
DATE SIGNED | 05/19/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90720612 |
Filing Date: 05/19/2021 |
The applicant's current Correspondence Information: |
Glenn A. Gundersen |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@dechert.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|